Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000082
Filing Date
2024-10-22
Accepted
2024-10-22 16:11:55
Documents
1
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1729627909.html 4  
1 FORM 4 wk-form4_1729627909.xml 4 20185
  Complete submission text file 0001649094-24-000082.txt   21741
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241386442

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)